| Dr Andrew Clark Mcafee, MD | |
|
6913 N Main St Ste 300, Granger, IN 46530-8039 | |
| (574) 647-1500 | |
| (574) 647-2567 |
| Full Name | Dr Andrew Clark Mcafee |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 6913 N Main St Ste 300, Granger, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558395079 | NPI | - | NPPES |
| 200889300 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01064116A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
| Elkhart General Hospital | Elkhart, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
A team of scientists from India has recently tested the efficacy and immunogenicity of two different concentrations of a plasmid DNA-based vaccine candidate ZyCoV-D. The findings reveal that the vaccine candidate administered via Needle Free Injection System (NFIS) can significantly induce the production of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific IgG and neutralizing antibodies for a prolonged period.
As main component of essential oils, terpenes can inhibit the growth of different cancer cells. Researchers from the Ruhr-University Bochum headed by Prof Dr Dr Dr Hanns Hatt have analysed this process in liver cancer cells in detail.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
University of Washington engineers are developing the first device able to transmit American Sign Language over U.S. cellular networks. The tool is just completing its initial field test by participants in a UW summer program for deaf and hard-of-hearing students.
› Verified 1 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
A team of scientists from India has recently tested the efficacy and immunogenicity of two different concentrations of a plasmid DNA-based vaccine candidate ZyCoV-D. The findings reveal that the vaccine candidate administered via Needle Free Injection System (NFIS) can significantly induce the production of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific IgG and neutralizing antibodies for a prolonged period.
As main component of essential oils, terpenes can inhibit the growth of different cancer cells. Researchers from the Ruhr-University Bochum headed by Prof Dr Dr Dr Hanns Hatt have analysed this process in liver cancer cells in detail.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
University of Washington engineers are developing the first device able to transmit American Sign Language over U.S. cellular networks. The tool is just completing its initial field test by participants in a UW summer program for deaf and hard-of-hearing students.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Clark Mcafee, MD 3245 Health Dr Ste 100, Granger, IN 46530-1380 Ph: () - | Dr Andrew Clark Mcafee, MD 6913 N Main St Ste 300, Granger, IN 46530-8039 Ph: (574) 647-1500 |
News Archive
A team of scientists from India has recently tested the efficacy and immunogenicity of two different concentrations of a plasmid DNA-based vaccine candidate ZyCoV-D. The findings reveal that the vaccine candidate administered via Needle Free Injection System (NFIS) can significantly induce the production of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific IgG and neutralizing antibodies for a prolonged period.
As main component of essential oils, terpenes can inhibit the growth of different cancer cells. Researchers from the Ruhr-University Bochum headed by Prof Dr Dr Dr Hanns Hatt have analysed this process in liver cancer cells in detail.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
University of Washington engineers are developing the first device able to transmit American Sign Language over U.S. cellular networks. The tool is just completing its initial field test by participants in a UW summer program for deaf and hard-of-hearing students.
› Verified 1 days ago
Dr. Leah Napolitano, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12563 State Rd 23, Granger, IN 46530 Phone: 574-335-8300 Fax: 574-335-0775 | |
Dr. Christopher J Quinn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 Fax: 574-273-5648 | |
Michael Dennison Conroy, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16205 Baywood Ln, Granger, IN 46530 Phone: 574-271-0244 | |
Dr. Joseph H Cerbin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 Fax: 574-273-5648 | |
Dr. Justin Reed, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 | |
Dr. David Charles Grellmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St, Granger, IN 46530 Phone: 574-647-1500 Fax: 574-243-4306 | |
Dr. Scott Michael Eshowsky, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St Ste 300, Granger, IN 46530 Phone: 574-647-1500 Fax: 574-647-2567 |